Literature DB >> 8283048

Protective immunity linked with a distinct developmental stage of a filarial parasite.

W F Eisenbeiss1, H Apfel, T F Meyer.   

Abstract

Repeated low dose infections of the jird Meriones unguiculatus, with the filarial parasite Acanthocheilonema viteae cause a substantial reduction of the total worm burden, suggesting a parasite-driven immune mechanism that controls super-infections. Quantitative recovery of parasites from tissues of triple infected jirds reveals that the larvae derived from a subsequent challenge infection are inactivated or severely impaired several days after transmission, precisely during their molt from the L3 to the L4 stage. Moreover, only larvae undergoing the molt from L3 to L4 stages are capable of stimulating an immune response directed against the challenge infection, indicating that protective Ag are produced during the molting period. Consistent with this, inactivated L3 or live L4 do not produce the same effect. In contrast to susceptible animals, immune jirds elicit high serum antibody titers against molting Ag. Indirect fluorescence antibody-binding tests with sera from protected jirds reveal specific labeling of the surface of molting L3 and not other larval stages, implying a stage-specific elimination process. The identification of molting L3 as a natural target for host immune mechanisms, emphasizes the central importance of this larval stage for future efforts aimed toward the development of a filarial vaccine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8283048

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Infection of BALB/c mice with the filarial nematode Litomosoides sigmodontis: role of CD4+ T cells in controlling larval development.

Authors:  K M Al-Qaoud; A Taubert; H Zahner; B Fleischer; A Hoerauf
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Transglutaminase-catalyzed reaction is important for molting of Onchocerca volvulus third-stage larvae.

Authors:  S Lustigman; B Brotman; T Huima; A L Castelhano; R N Singh; K Mehta; A M Prince
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

3.  Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors:  D Abraham; O Leon; S Leon; S Lustigman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

Authors:  M Lizotte-Waniewski; W Tawe; D B Guiliano; W Lu; J Liu; S A Williams; S Lustigman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.

Authors:  P S Turaga; T J Tierney; K E Bennett; M C McCarthy; S C Simonek; P A Enyong; D W Moukatte; S Lustigman
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  Onchocerca volvulus larval antigen, OvB20, induces partial protection in a rodent model of onchocerciasis.

Authors:  M J Taylor; N Abdel-Wahab; Y Wu; R E Jenkins; A E Bianco
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.

Authors:  Fidelis Cho-Ngwa; Jing Liu; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2010-08-24

8.  Resistance and susceptibility to filarial infection with Litomosoides sigmodontis are associated with early differences in parasite development and in localized immune reactions.

Authors:  Simon Babayan; Marie-Noëlle Ungeheuer; Coralie Martin; Tarik Attout; Elodie Belnoue; Georges Snounou; Laurent Rénia; Masataka Korenaga; Odile Bain
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.

Authors:  S K Joseph; K Ramaswamy
Journal:  Vaccine       Date:  2013-06-02       Impact factor: 3.641

10.  Transcriptomes and pathways associated with infectivity, survival and immunogenicity in Brugia malayi L3.

Authors:  Ben-Wen Li; Amy C Rush; Makedonka Mitreva; Yong Yin; David Spiro; Elodie Ghedin; Gary J Weil
Journal:  BMC Genomics       Date:  2009-06-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.